ZBH
Zimmer BiometPrevious close
94.52
Change
−2.95 / −3.03%
P/E (TTM) ?
22.3
Market Cap
$18.8B
1M
+6.41%
S&P 500 −0.91% over same period
Volume / Avg Volume
3.6M / 1.9M
1.95× average
Latest earnings analysisFY2026 Q2Reported 2026-08-05
Zimmer Biomet Q2 FY2026: revenue up 4.8%, adjusted EPS flat
Zimmer Biomet's Q2 FY2026 revenue grew 4.8% to $2.177 billion, but adjusted diluted EPS was $2.07, flat versus last year and just above the $2.0294 consensus estimate. GAAP EPS jumped 33.8% to $1.03 on lower tax and restructuring charges, while gross margin slipped to 70.8%. The company raised full-year guidance on both revenue and adjusted EPS, so the quarter supports a neutral stance: steady execution, but no acceleration in underlying profitability.
Read the full analysis →Revenue$2.18BYoY +4.80%
EPS (non-GAAP)$2.07Beatest. $2.03
Next-day move−0.99%
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | Analysis |
|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-08-05 | $2.2B | Read analysis → |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-28 | $2.1B | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-10 | $8.2B | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-11-05 | $2.0B | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-08-07 | $2.1B | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-05-05 | $1.9B | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 28 of its 5-year rangeCheap
5-year range 20.4 – 52.4 · Median 23.7
Last 4 quarters: $751M in buybacks + $188M in dividends, 5.00% of market cap combined
P/E (TTM)
22.3
P/B
1.4
P/S
2.1
Dividend Yield
1.04%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.1% on average on the first trading day after, rising 4 times
Most recent −0.99%
Volatility & Correlation
1-year beta -0.20 · Correlation with S&P 500 -0.08Low beta
Annualized volatility 30% vs. 12% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
Buy 0 · $0.00MSell 2 · $0.82MNet selling $0.82M
- 09-11Thornal Kevin RGrp Pres-Global BusinessSell$0.53M5,691 shares · Avg price 92.95
- 09-04Phipps Chad FSee remarks below.Sell$0.30M3,000 shares · Avg price 98.35
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q2 | 2.18 | +4.8% | 70.8% | 0.20 | 1.03 |
| FY2026 Q1 | 2.09 | +9.3% | 72.4% | 0.24 | 1.22 |
| FY2025 Q4 | 2.24 | +10.9% | 64.7% | 0.14 | 0.71 |
| FY2025 Q3 | 2.00 | +9.7% | 72.1% | 0.23 | 1.16 |
| FY2025 Q2 | 2.08 | +7.0% | 71.5% | 0.15 | 0.77 |
| FY2025 Q1 | 1.91 | +1.1% | 71.2% | 0.18 | 0.91 |
| FY2024 Q4 | 2.02 | +4.3% | 71.0% | 0.24 | 1.18 |
| FY2024 Q3 | 1.82 | +4.0% | 70.5% | 0.25 | 1.23 |
| FY2024 Q2 | 1.94 | +3.9% | 71.5% | 0.24 | 1.18 |
| FY2024 Q1 | 1.89 | +3.2% | 72.9% | 0.17 | 0.84 |
| FY2023 Q4 | 1.94 | +6.3% | 72.2% | 0.42 | 2.00 |
| FY2023 Q3 | 1.75 | +5.0% | 70.4% | 0.16 | 0.77 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| ZBH | 22.3 | +4.8% | 70.8% | +6.41% | Neutral |
| LLY | 50.2 | +38.6% | 83.9% | +22.51% | Bullish |
| JNJ | 41.3 | +5.9% | 68.1% | +3.20% | Bullish |
| ABBV | 81.4 | +10.2% | 74.7% | +12.73% | Bullish |
| UNH | 23.0 | +0.4% | 88.1% | +10.87% | Bullish |
| MRK | 117.2 | +5.1% | 73.5% | +2.90% | Neutral |
| TMO | 36.4 | +9.1% | — | +3.25% | Neutral |
| AMGN | 28.5 | +9.5% | 72.0% | +10.56% | Bullish |
| GILD | — | +6.8% | 81.1% | +14.51% | Neutral |